Valuation: Strides Pharma Science Limited

Market Cap 100B 1.05B 943M 871M 789M 1.47B 1.49B 10.42B 4.15B 52.36B 3.94B 3.86B 166B P/E 2027 *
15.9x
P/E 2028 * 11.4x
Enterprise Value 100B 1.05B 943M 871M 789M 1.47B 1.49B 10.42B 4.15B 52.36B 3.94B 3.86B 166B EV / Sales 2027 *
1.72x
EV / Sales 2028 * 1.45x
Free-Float
68.12%
Yield 2027 *
0.28%
Yield 2028 * 0.28%
1 day-0.70%
1 week+5.47%
Current month-3.07%
1 month-8.38%
3 months+4.08%
6 months-1.18%
Current year+20.58%
1 week 980.4
Extreme 980.4
1,116.4
1 month 980.4
Extreme 980.4
1,182.5
Current year 768.65
Extreme 768.65
1,260.9
1 year 768.65
Extreme 768.65
1,260.9
3 years 467
Extreme 467
1,675
5 years 263.35
Extreme 263.35
1,675
10 years 263.35
Extreme 263.35
1,675
Manager TitleAgeSince
Chief Executive Officer - 01/06/2024
Director of Finance/CFO 42 01/06/2024
Chief Tech/Sci/R&D Officer - 21/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member - 18/05/2017
Director/Board Member 82 18/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.70%+5.47%+33.09%+117.88% 1.06B
+0.49%+1.36%+57.05%+127.67% 1,143B
+0.74%+5.10%+44.93%+84.26% 647B
+0.36%+0.94%+26.35%+102.61% 506B
-0.05%+1.73%+52.74%+65.27% 384B
-1.01%-6.18%+61.56%+36.94% 350B
+0.34%+1.84%+30.70%+52.69% 293B
-0.45%+1.19%+2.89%+24.92% 265B
+0.48%+2.58%+53.94%+70.85% 242B
+0.29%+3.84%+35.27%+105.04% 197B
Average +0.05%+1.38%+39.85%+78.81% 402.86B
Weighted average by Cap. +0.24%+0.71%+44.49%+86.98%

Financials

2027 *2028 *
Net sales 58.23B 611M 549M 507M 459M 858M 868M 6.06B 2.42B 30.47B 2.29B 2.25B 96.73B 69.12B 726M 651M 602M 545M 1.02B 1.03B 7.2B 2.87B 36.17B 2.72B 2.67B 115B
Net income 6.28B 65.91M 59.13M 54.67M 49.52M 92.51M 93.63M 654M 260M 3.28B 247M 242M 10.43B 8.8B 92.38M 82.88M 76.63M 69.4M 130M 131M 916M 365M 4.6B 347M 339M 14.62B
Net Debt - -
Projected Income Statement - Annual - Strides Pharma Science Limited
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,535
Date Price Change Volume
28/10/26 ₹1,085.60 -0.70% 396,045
27/10/26 ₹1,093.30 +5.83% 787,306
26/10/26 ₹1,033.10 +1.80% 281,520
23/10/26 ₹1,014.80 +1.64% 312,385
22/10/26 ₹998.40 -2.62% 223,577
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Strides Pharma Science Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,085.60INR
Average target price
1,338.67INR
Spread / Average Target
+23.31%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Strides Pharma Science Limited
  1. Stock Market
  2. Stocks
  3. STAR Stock